Advanced age does not increase morbidity after total thyroidectomy. Result of a prospective study.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
04 2019
Historique:
received: 23 04 2018
revised: 07 07 2018
accepted: 12 07 2018
pubmed: 30 7 2018
medline: 19 12 2019
entrez: 30 7 2018
Statut: ppublish

Résumé

It is well known that total thyroidectomy is feasible on elderly patients but is linked to complications because of their underlying comorbidities. In this study we analyzed the specific risks linked to surgery, hypoparathyroidism and recurrent nerve palsy. materials-methods:Prospective, multicentre trial conducted at 13 hospital sites. The primary endpoint was the percentage of patients with postoperative hypocalcaemia (albumin-corrected serum calcium level <2 mmol/L at day 2). Secondary endpoints included recurrent nerve palsy rate at day 2, the percentage of patients with hypocalcaemia (serum calcium level <2 mmol/L) and recurrent nerve palsy at month 6, operating durations and postoperative pain. Patients were separated in two groups: <70 years and ≥70 years old. In total, 1329 patients who underwent total thyroidectomy were included (median age 51.17 years [18.10; 80.90], 80% women, and hyperthyroidism in 20%, 101 ≥ 70 years old). Rates of hypocalcaemia at day 2 and month 6 were 20.02% and 1.98% respectively. Nasofibroscopy showed postoperative abnormal vocal cord motility in 9.92% cases (hypo-motility 5.76% - immobility 4.16%) and 0.95% at month 6 (hypo-motility 0.48%, immobility 0.48%). Patients ≥70 years had a lower (but non-significant) postoperative and definitive hypocalcaemia rate than patients < 70 years: 14.85% vs 20.44% at day 2 (p = 0.1773) and 0% vs 2.15% at month 6 respectively (p = 0.2557). Abnormal vocal cord motility rate was 12.00% in patients ≥70 years vs 9.75% in patients <70 years at day 2 (p = 0.4702), and 2.06% in patients ≥70 years vs 0.86% at month 6 (p = 0.2340). Total thyroidectomy in patients ≥70 years is feasible and safe. Age does not increase the morbidity. The study is registered with ClinicalTrials.gov number NCT01551914.

Sections du résumé

BACKGROUND
It is well known that total thyroidectomy is feasible on elderly patients but is linked to complications because of their underlying comorbidities. In this study we analyzed the specific risks linked to surgery, hypoparathyroidism and recurrent nerve palsy.
METHODS
materials-methods:Prospective, multicentre trial conducted at 13 hospital sites. The primary endpoint was the percentage of patients with postoperative hypocalcaemia (albumin-corrected serum calcium level <2 mmol/L at day 2). Secondary endpoints included recurrent nerve palsy rate at day 2, the percentage of patients with hypocalcaemia (serum calcium level <2 mmol/L) and recurrent nerve palsy at month 6, operating durations and postoperative pain. Patients were separated in two groups: <70 years and ≥70 years old.
RESULTS
In total, 1329 patients who underwent total thyroidectomy were included (median age 51.17 years [18.10; 80.90], 80% women, and hyperthyroidism in 20%, 101 ≥ 70 years old). Rates of hypocalcaemia at day 2 and month 6 were 20.02% and 1.98% respectively. Nasofibroscopy showed postoperative abnormal vocal cord motility in 9.92% cases (hypo-motility 5.76% - immobility 4.16%) and 0.95% at month 6 (hypo-motility 0.48%, immobility 0.48%). Patients ≥70 years had a lower (but non-significant) postoperative and definitive hypocalcaemia rate than patients < 70 years: 14.85% vs 20.44% at day 2 (p = 0.1773) and 0% vs 2.15% at month 6 respectively (p = 0.2557). Abnormal vocal cord motility rate was 12.00% in patients ≥70 years vs 9.75% in patients <70 years at day 2 (p = 0.4702), and 2.06% in patients ≥70 years vs 0.86% at month 6 (p = 0.2340).
CONCLUSIONS
Total thyroidectomy in patients ≥70 years is feasible and safe. Age does not increase the morbidity. The study is registered with ClinicalTrials.gov number NCT01551914.

Identifiants

pubmed: 30055804
pii: S0002-9610(18)30599-3
doi: 10.1016/j.amjsurg.2018.07.029
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01551914']

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

767-771

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Niki Christou (N)

CHU de Limoges - Hôpital Dupuytren, Chirurgie Digestive, Générale et Endocrinienne, Limoges Cedex, 87042, France. Electronic address: christou.niki19@gmail.com.fr.

Claire Blanchard (C)

CHU de Nantes, Clinique de Chirurgie Digestive et Endocrinienne (CCDE), Nantes Cedex 1, 44093, France. Electronic address: claire.blanchard@chu-nantes.fr.

François Pattou (F)

CHU Lille, Université de Lille, Chirurgie Générale et Endocrinienne, Lille, 59000, France. Electronic address: fpattou@univ-lille2.fr.

Christelle Volteau (C)

DRCI, Département Promotion, Nantes Cedex 1, 44093, France. Electronic address: christelle.volteau@chu-nantes.fr.

Laurent Brunaud (L)

CHU Nancy - Hôpital de Brabois, Service de Chirurgie Digestive, Hépato-biliaire, et Endocrinienne, Nancy, 54000, France. Electronic address: l.brunaud@chu-nancy.fr.

Antoine Hamy (A)

CHU Angers, Chirurgie Digestive et Endocrinienne, Angers Cedex 09, 49933, France. Electronic address: anhamy@chu-angers.fr.

Marcel Dahan (M)

CHU de Toulouse - Hôpital Larrey, Chirurgie Thoracique, Pôle Voies Respiratoires, Toulouse Cedex 9, 31059, France. Electronic address: dahan.m@chu-toulouse.fr.

Jean-Michel Prades (JM)

CHU Saint-Etienne - Hôpital Nord, ORL et Chirurgie Cervico-faciale et Plastique, Saint-Etienne Cedex 2, 42055, France. Electronic address: j.michel.prades@chu-st-etienne.fr.

Gérard Landecy (G)

CHU de Besançon - Hôpital Jean Minjoz, Chirurgie Digestive, Besançon Cedex, 25030, France. Electronic address: gerard.landecy@wanadoo.fr.

Henri-Pierre Dernis (HP)

Centre Hospitalier Du Mans, Service ORL et Chirurgie Cervico-faciale, Le Mans Cedex 9, 72037, France. Electronic address: phdernis@ch-lemans.fr.

Jean-Christophe Lifante (JC)

Centre Hospitalier Lyon-Sud, Chirurgie Générale, Endocrinienne, Digestive et Thoracique, Pierre Bénite Cedex, 69495, France. Electronic address: Jean-christophe.lifante@chu-lyon.fr.

Fréderic Sebag (F)

AP-HM - Hôpital de La Timone, Chirurgie Générale, Marseille, 13005, France. Electronic address: frederic.sebag@ap-hm.fr.

Franck Jegoux (F)

CHU de Rennes - Hôpital Pontchaillou, Service ORL et Chirurgie Maxillo-faciale, Rennes Cedex 9, 35033, France. Electronic address: franck.jegoux@chu-rennes.fr.

Emmanuel Babin (E)

CHU de Caen, ORL et Chirurgie Cervico-faciale, Caen Cedex 9, 14033, France. Electronic address: babin-e@chu-caen.fr.

Alain Bizon (A)

CHU D'Angers, ORL et Chirurgie Cervico-faciale, Angers Cedex 09, 49933, France. Electronic address: albizon@chu-angers.fr.

Cécile Caillard (C)

CHU de Nantes, Clinique de Chirurgie Digestive et Endocrinienne (CCDE), Nantes Cedex 1, 44093, France. Electronic address: cecile.caillard@chu-nantes.fr.

Muriel Mathonnet (M)

CHU de Limoges - Hôpital Dupuytren, Chirurgie Digestive, Générale et Endocrinienne, Limoges Cedex, 87042, France. Electronic address: mathonnet@unilim.fr.

Eric Mirallié (E)

CHU de Nantes, Clinique de Chirurgie Digestive et Endocrinienne (CCDE), Nantes Cedex 1, 44093, France. Electronic address: eric.mirallie@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH